Peli BioThermal Partnership With Asiana Airlines Announced

Providing pandemic response support sees company’s Crēdo™ on Demand network expand with latest airline cargo collaboration

Peli BioThermal, global name in temperature-controlled packaging, has announced its latest partnership with Asiana Airlines, which will see an extensive expansion of the company’s growing global network.

In the ongoing rapid response to support the global fight against COVID-19, the new partnership provides Asiana Airlines access to Peli BioThermal’s Crēdo™ on Demand rental program when shipping temperature-sensitive pharmaceutical and pandemic payloads worldwide.

The collaboration allows Peli BioThermal to continue to grow its global network of key locations and significant sector alliances to further meet the needs of its customers. It provides Asiana Airlines customers with Peli BioThermal’s high-performing shipper solutions, including the company’s recently expanded range of temperature-controlled packaging to cover both deep-frozen and frozen applications, which include dry ice and PCM coolants, covering parcel and bulk sizes for single or multi-use / reusable including rental through the Crēdo™ on Demand program.

Dominic Hyde, Vice President of Crēdo™ on Demand at Peli BioThermal, said: “I’m excited to announce another airline partnership on the Pacific Rim, particularly another in the Republic of Korea. It has such a key role in the production of ingredients, which are shipped globally and turned into finished drug products. Additionally, Asiana Airlines acquired the IATA CEIV Pharma certification for complete cold chain management, so our partnership is strengthened by our complementary offerings to pharmaceutical manufacturers.”

Visit www.pelibiothermal.com to learn more about the wide range of Peli BioThermal products and offerings.

Peli BioThermal is a division of Peli Products, S.L.U., which is the European arm of Pelican Products, Inc., which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.